The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice
Open accessAbstract
PTEN (phosphatase and tensin homolog deleted on chromosome ten) is a lipid phosphatase that counteracts the function of phosphatidylinositol-3 kinase (PI3K). Loss of function of PTEN results in constitutive activation of AKT and downstream effectors and correlates with many human cancers, as well as various brain disorders, including macrocephaly, seizures, Lhermitte–Duclos disease, and autism. We previously generated a conditional Pten knock-out mouse line with Pten loss in limited postmitotic neurons in the cortex and hippocampus.Pten-null neurons developed neuronal hypertrophy and loss of neuronal polarity. The mutant mice exhibited macrocephaly and behavioral abnormalities reminiscent of certain features of human autism. Here, we report that rapamycin, a specific inhibitor of mammalian target of rapamycin complex 1 (mTORC1), can prevent and reverse neuronal hypertrophy, resulting in the amelioration of a subset of PTEN-associated abnormal behaviors, providing evidence that the mTORC1 pathway downstream of PTEN is critical for this complex phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally in animal models of autism spectrum disorder (ASD), altered mTORC1 signaling contributes to the observed synaptic dysfunction and aberrant network connectivity (13,15,(21)(22)(23)(24)(25)(26)(27).”
From Analysis of proteins that rapidly change upon mechanistic/mammalian target of rapamycin complex 1 (mTORC1) repression identifies parkinson protein 7 (PARK7) as a novel protein aberrantly expressed in tuberous sclerosis complex (TSC) (2016) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Notably, pharmacological and genetic manipulations have successfully rescued both structural and behavioral phenotypes in PTEN86, FMR1 (ref. 87) and MECP2 (ref. 88) knockout mice.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [86]
In the citing paper
“That behavioral recovery in each of these rescue strategies was paralleled by reversal of spine pathologies underscores the importance of these structural perturbations in the pathogenesis of ASDs and comorbid disorders and the potential for the use of animal models in the development of therapeutics.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [86]
In the citing paper
“Rapamycin successfully reduced cognitive impairment and social behavior deficit in mouse models of tuberous sclerosis 61-63 and improved behavior in adult mice with a deletion of PTEN 64 .”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [64]
In the citing paper
“Experimental interventions, working through diverse genetic and pharmacological mechanisms, rescue subsets of behavioral abnormalities in these mouse models (31, 43, 48–52).”
From Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism (2012) · cites this paper as [52]
In the citing paper
“Target strategies draw from therapeutics under investigation for other neurodevelopmental disorders and hypotheses emerging from mutations in synaptic genes identified in small numbers of individuals with autism spectrum disorders (43, 49, 52).”
From Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism (2012) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Self-citationTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,055
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Pten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970
Self-citationAkt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882
Cited by
Sorted by citations
Items 101–200 of 441
mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia
Nguyen, L. H., Brewster, A. L., Clark, M. E., Regnier‐Golanov, A., Sunnen, C. N., Patil, V., D’Arcangelo, G., & Anderson, A. E. (2015) · Epilepsia · doi:10.1111/epi.12946 · Cited by 106
Chen, H.-C., Fong, T.-H., Hsu, P., & Chiu, W. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.02.023 · Cited by 107
Sperow, M., Berry, R. B., Bayazitov, I. T., Zhu, G. G., Baker, S. J., & Zakharenko, S. S. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.220236 · Cited by 103
Neuronal Autophagy and Neurodevelopmental Disorders
Lee, K., Hwang, S.-K., & Lee, J. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.3.133 · Cited by 101
Deregulated mTOR-mediated translation in intellectual disability
Troca-Marín, J. A., Alves-Sampaio, A., & Montesinos, M. L. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.005 · Cited by 109
Pathogenetic mechanisms of focal cortical dysplasia
Marin‐Valencia, I., Guerrini, R., & Gleeson, J. G. (2014) · Epilepsia · doi:10.1111/epi.12650 · Cited by 100
Tau Reduction Prevents Key Features of Autism in Mouse Models
Tai, C., Chang, C.-W., Yu, G.-Q., Lopez, I., Yu, X., Wang, X., Guo, W., & Mucke, L. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.038 · Cited by 96
mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder
Thomas, S. D., Jha, N. K., Ojha, S. K., & Sadek, B. S. (2023) · Molecules · doi:10.3390/molecules28041889 · Cited by 106
mTOR Inhibition in Epilepsy: Rationale and Clinical Perspectives
Ostendorf, A. P., & Wong, M. (2015) · CNS Drugs · doi:10.1007/s40263-014-0223-x · Cited by 96
Weber, J. D., & Gutmann, D. H. (2012) · Cell Cycle · doi:10.4161/cc.11.2.19022 · Cited by 97
Autism Spectrum Disorders: Translating human deficits into mouse behavior
Pasciuto, E., Borrie, S. C., Kanellopoulos, A. K., Santos, A. R. S., Cappuyns, E., D’Andrea, L., Pacini, L., & Bagni, C. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.07.013 · Cited by 103
Frontier of Epilepsy Research - mTOR signaling pathway
Cho, C. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.5.032 · Cited by 93
A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons
Lin, Y., Frei, J. A., Kilander, M. B. C., Shen, W., & Blatt, G. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00263 · Cited by 97
Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder
Onore, C. E., Yang, H. T., de Water, J. V., & Ashwood, P. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00043 · Cited by 94
Metformin for treatment of fragile X syndrome and other neurological disorders
Gantois, I., Popic, J., Khoutorsky, A., & Sonenberg, N. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-081117-041238 · Cited by 87
Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice
Steinmetz, A. B., Stern, S. A., Kohtz, A. S., Descalzi, G., & Alberini, C. M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2010-17.2017 · Cited by 90
Effects of Intermittent Fasting on Brain Metabolism
Brocchi, A., Rebelos, E., Dardano, A., Mantuano, M., & Daniele, G. (2022) · Nutrients · doi:10.3390/nu14061275 · Cited by 99
Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy
Hodges, S. L., & Lugo, J. N. (2020) · Epilepsy Research · doi:10.1016/j.eplepsyres.2020.106282 · Cited by 88
Kreis, P., Leondaritis, G., Lieberam, I., & Eickholt, B. J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00023 · Cited by 87
FMR1 premutation and full mutation molecular mechanisms related to autism
Hagerman, R., Au, J., & Hagerman, P. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9084-5 · Cited by 85
Curatolo, P., Napolioni, V., & Moavero, R. (2010) · Journal of Child Neurology · doi:10.1177/0883073810361789 · Cited by 84
Iyer, J. S., Singh, M. D., Jensen, M., Patel, P. T., Pizzo, L., Huber, E., Koerselman, H., Weiner, A. T., Lepanto, P., Vadodaria, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04882-6 · Cited by 81
Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder
Tilot, A. K., Frazier, T. W., & Eng, C. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0356-8 · Cited by 87
Homberg, J. R., Kyzar, E. J., Nguyen, M., Norton, W., Pittman, J. T., Poudel, M. K., Gaikwad, S., Nakamura, S., Koshiba, M., Yamanouchi, H., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.013 · Cited by 86
PTEN Hamartoma tumor syndrome in childhood: A review of the clinical literature
Macken, W. L., Tischkowitz, M. D., & Lachlan, K. L. (2019) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31743 · Cited by 79
Genomics in neurodevelopmental disorders: an avenue to personalized medicine
Tărlungeanu, D. C., & Novarino, G. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0129-7 · Cited by 86
The Role of PTEN in Neurodevelopment
Skelton, P. D., Stan, R. V., & Luikart, B. W. (2019) · Complex Psychiatry · doi:10.1159/000504782 · Cited by 82
Overview of Mouse Models of Autism Spectrum Disorders
Bey, A. L., & Jiang, Y. (2014) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0566s66 · Cited by 85
Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis
McDaniel, S. S., & Wong, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.037 · Cited by 78
Bell, J. J. L., Rakhade, S. N., Klein, P., Obeid, M., Jackson, M. C., Joseph, A., & Jensen, F. E. (2013) · Epilepsia · doi:10.1111/epi.12378 · Cited by 79
Nam, J. H., Leem, E., Jeon, M.-T., Jeong, K. H., Park, J.-W., Jung, U. J., Kholodilov, N., Burke, R. E., Jin, B. K., & Kim, S. R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8729-2 · Cited by 76
Neurobiology of autism gene products: towards pathogenesis and drug targets
Kleijer, K. T. E., Schmeißer, M. J., Krueger‐Burg, D., Boeckers, T. M., Scheiffele, P., Bourgeron, T., Brose, N., & Burbach, J. P. H. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3403-3 · Cited by 80
PTEN: Local and Global Modulation of Neuronal Function in Health and Disease
Knafo, S., & Esteban, J. A. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2016.11.008 · Cited by 79
Tilot, A. K., Gaugler, M. K., Yu, Q., Romigh, T., Yu, W., Miller, R. H., Frazier, T. W., & Eng, C. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu031 · Cited by 72
Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy
Talos, D. M., Jacobs, L., Gourmaud, S., Coto, C. A., Sun, H., Lim, K., Lucas, T. H., Davis, K. A., Martinez‐Lage, M., & Jensen, F. E. (2018) · Annals of Neurology · doi:10.1002/ana.25149 · Cited by 76
Characterizing autism spectrum disorders by key biochemical pathways
Subramanian, M. P., Timmerman, C., Schwartz, J. L., Pham, D. L., & Meffert, M. K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00313 · Cited by 71
The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids
van Sadelhoff, J. H. J., Perez Pardo, P., Wu, J., Garssen, J., van Bergenhenegouwen, J., Hogenkamp, A., Hartog, A., & Kraneveld, A. D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00247 · Cited by 71
Food allergy and food‐based therapies in neurodevelopmental disorders
de Theije, C. G. M., Bavelaar, B. M., da Silva, S. L., Korte, S. M., Olivier, B., Garssen, J., & Kraneveld, A. D. (2013) · Pediatric Allergy and Immunology · doi:10.1111/pai.12149 · Cited by 71
Neuropathology and Animal Models of Autism: Genetic and Environmental Factors
Gadad, B. S., Hewitson, L. C., Young, K. A., & German, D. C. (2013) · Autism Research and Treatment · doi:10.1155/2013/731935 · Cited by 72
A conserved PTEN/FOXO pathway regulates neuronal morphology duringC. elegansdevelopment
Christensen, R. P., de la Torre-Ubieta, L., Bonni, A., & Colón‐Ramos, D. A. (2011) · Development · doi:10.1242/dev.069062 · Cited by 67
Luckhart, S., Giulivi, C., Drexler, A., Antonova‐Koch, Y., Sakaguchi, D., Napoli, E., Wong, S., Price, M. S., Eigenheer, R. A., Phinney, B. S., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003180 · Cited by 68
The Neurodevelopmental Implications of PI3K Signaling
Waite, K., & Eickholt, B. J. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_82 · Cited by 65
Mouse Models of Autism: Testing Hypotheses About Molecular Mechanisms
Roullet, F., & Crawley, J. N. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_113 · Cited by 67
Postsynaptic autism spectrum disorder genes and synaptic dysfunction
Bonsi, P., Jaco, A. D., Fasano, L., & Gubellini, P. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105564 · Cited by 68
Ohja, K., Gozal, E., Fahnestock, M. L., Cai, L., Cai, J., Freedman, J. H., Switala, A., El-Baz, A. S., & Barnes, G. N. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8488-8 · Cited by 66
PTEN Regulation of Local and Long-Range Connections in Mouse Auditory Cortex
Xiong, Q., Oviedo, H. V., Trotman, L. C., & Zador, A. M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4480-11.2012 · Cited by 60
Kim, S.-H., Speirs, C. K., Solnica‐Krezel, L., & Ess, K. C. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005587 · Cited by 61
Zhou, J., Brugarolas, J., & Parada, L. F. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp398 · Cited by 61
Self-citationKachaylo, E., Tschuor, C., Calo, N., Borgeaud, N., Ungethüm, U., Limani, P., Piguet, A., Dufour, J., Foti, M., Graf, R., et al. (2017) · Hepatology · doi:10.1002/hep.29226 · Cited by 66
Veeraragavan, S., Bui, N., Perkins, J. R., Yuva‐Paylor, L. A., Carpenter, R. L., & Paylor, R. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2276-6 · Cited by 63
Magdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 60
Ryther, R. C. C., & Wong, M. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0276-5 · Cited by 60
Current perspectives in autism spectrum disorder: from genes to therapy
Chahrour, M., O'Roak, B. J., Santini, E., Samaco, R. C., Kleiman, R. J., & Manzini, M. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2335-16.2016 · Cited by 54
García‐Junco‐Clemente, P., & Golshani, P. (2014) · Communicative & Integrative Biology · doi:10.4161/cib.28358 · Cited by 57
PTEN deletion increases hippocampal granule cell excitability in male and female mice
Santos, V. R., Pun, R. Y. K., Arafa, S. R., LaSarge, C. L., Rowley, S. D., Khademi, S., Bouley, T., Holland, K. D., Garcia‐Cairasco, N., & Danzer, S. C. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.014 · Cited by 57
Kotajima‐Murakami, H., Kobayashi, T., Kashii, H., Sato, A., Hagino, Y., Tanaka, M., Nishito, Y., Takamatsu, Y., Uchino, S., & Ikeda, K. (2019) · Molecular Brain · doi:10.1186/s13041-018-0423-2 · Cited by 57
Burket, J. A., Benson, A. D., Tang, A., & Deutsch, S. I. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.05.003 · Cited by 57
Disruption of mTORC1 rescues neuronal overgrowth and synapse function dysregulated by Pten loss
Tariq, K., Cullen, E. R., Getz, S. A., Conching, A., Goyette, A. R., Prina, M. L., Wang, W., Li, M., Weston, M. C., & Luikart, B. W. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111574 · Cited by 58
Wong, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.002 · Cited by 56
Napoli, E., Hung, C., Wong, S., & Giulivi, C. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs339 · Cited by 56
PTEN knockdown alters dendritic spine/protrusion morphology, not density
Haws, M. E., Jaramillo, T. C., Espinosa, F., Widman, A. J., Stuber, G. D., Sparta, D. R., Tye, K. M., Russo, S. J., Parada, L. F., Stavarache, M. A., et al. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23488 · Cited by 56
Self-citationMalik, R., Pai, E. L.-L., Rubin, A. N., Stafford, A. M., Angara, K., Minasi, P., Rubenstein, J. L. R., Sohal, V. S., & Vogt, D. L. (2019) · Nature Communications · doi:10.1038/s41467-019-12962-4 · Cited by 55
Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders
Singh, A. A., Katiyar, S., & Song, M. (2025) · Brain Sciences · doi:10.3390/brainsci15030252 · Cited by 61
Role of mTOR inhibitors in epilepsy treatment
Sadowski, K., Kotulska, K., & Jóźwiak, S. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.017 · Cited by 51
Mahmood, U., Ahn, S., Yang, E.-J., Choi, M., Kim, H.-J., Regan, P. L., Cho, K., & Kim, H.-S. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.006 · Cited by 54
Rapamycin prevents, but does not reverse, aberrant migration in Pten knockout neurons
Getz, S. A., DeSpenza, T., Li, M., & Luikart, B. W. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.010 · Cited by 50
Epilepsy and malformations of cortical development
Kuzniecky, R. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000175 · Cited by 49
mTOR inhibitors as a new therapeutic option for epilepsy
Curatolo, P., & Moavero, R. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.49 · Cited by 46
Mtor As A Potential Treatment Target For Epilepsy
Wong, M. (2012) · Future Neurology · doi:10.2217/fnl.12.45 · Cited by 46
Adult reversal of cognitive phenotypes in neurodevelopmental disorders
Silva, A. J., & Ehninger, D. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9018-7 · Cited by 45
Lieberman, O. J., Cartocci, V., Pigulevskiy, I., Molinari, M., Carbonell, J., Broseta, M. B., Post, M. R., Sulzer, D., Borgkvist, A., & Santini, E. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00070 · Cited by 48
Klofas, L. K., Short, B. P., Zhou, C.-W., & Carson, R. P. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa068 · Cited by 42
Kazdoba, T. M., Sunnen, C., Crowell, B., Lee, G., Anderson, A., & D'Arcangelo, G. (2012) · Developmental Neuroscience · doi:10.1159/000337229 · Cited by 43
KIF2A regulates the development of dentate granule cells and postnatal hippocampal wiring
Homma, N., Zhou, R., Naseer, M. I., Chaudhary, A., Al-Qahtani, M. H., & Hirokawa, N. (2018) · eLife · doi:10.7554/elife.30935 · Cited by 44
Schubert‐Bast, S., Rosenow, F., Klein, K. M., Reif, P. S., Kieslich, M., & Strzelczyk, A. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.05.039 · Cited by 44
Zhu, J.-W., Zou, M.-M., Li, Y.-F., Chen, W.-J., Liu, J.-C., Chen, H., Fang, L., Zhang, Y., Wang, Z.-T., Chen, J.-B., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz306 · Cited by 43
Chapter 8 Translational Regulatory Mechanisms in Synaptic Plasticity and Memory Storage
Costa‐Mattioli, M., Sonenberg, N., & Richter, J. D. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)90008-4 · Cited by 43
Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex
Sundberg, M., & Şahin, M. (2015) · Journal of Child Neurology · doi:10.1177/0883073815600870 · Cited by 45
Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy
Huang, X., McMahon, J. J., & Huang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.011 · Cited by 42
Canpolat, M., Per, H., Gumus, H., Yıkılmaz, A., Unal, E., Patiroglu, T., Çinar, L., Kurtsoy, A., & Kumandaş, S. (2014) · Child's Nervous System · doi:10.1007/s00381-013-2185-6 · Cited by 43
Ohashi, R., Takao, K., Miyakawa, T., & Shiina, N. (2016) · Scientific Reports · doi:10.1038/srep20775 · Cited by 45
Papke, C. M., Smolen, K. A., Swingle, M. R., Cressey, L. E., Heng, R. A., Toporsian, M., Deng, L., Hagen, J., Shen, Y., Chung, W. K., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100313 · Cited by 35
Satellite glia modulate sympathetic neuron survival, activity, and autonomic function
Mapps, A. A., Boehm, E. D., Beier, C., Keenan, W. T., Langel, J., Liu, M., Thomsen, M. B., Hattar, S. S., Zhao, H., Tampakakis, E., et al. (2022) · eLife · doi:10.7554/elife.74295 · Cited by 46
Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism
Silverman, J. L., Babineau, B. A., Oliver, C. F., Karras, M. N., & Crawley, J. N. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.042 · Cited by 46
Machado, C. D. O. F., Griesi‐Oliveira, K., Rosenberg, C., Kok, F., Martins, S., Passos‐Bueno, M. R., & Sertie, A. L. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.69 · Cited by 41
Genetic animal models of malformations of cortical development and epilepsy
Wong, M., & Roper, S. N. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.04.007 · Cited by 40
DeSpenza, T., Carlson, M., Panchagnula, S., Robert, S. M., Duy, P. Q., Mermin‐Bunnell, K., Reeves, B. C., Kundishora, A. J., Elsamadicy, A. A., Smith, H. L., et al. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.08.007 · Cited by 42
Sato, A., Kotajima‐Murakami, H., Tanaka, M., Katoh, Y., & Ikeda, K. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.821455 · Cited by 44
Long, J., Li, H., Liu, Y., Liao, X., Tang, Z., Han, K., Chen, J., & Zhang, H. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1364858 · Cited by 43
LaSarge, C. L., Santos, V. R., & Danzer, S. C. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.029 · Cited by 40
Kreis, P., Hendricusdottir, R., Kay, L., Papageorgiou, I. E., van Diepen, M. T., Mack, T. G. A., Ryves, J., Harwood, A. J., Leslie, N. R., Kann, O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071957 · Cited by 40
Dysregulation of mTOR Signaling in Neuropsychiatric Disorders: Therapeutic Implications
Sawicka, K., & Zukin, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.210 · Cited by 41
Zeng, L. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.16 · Cited by 39
Nguyen, L. H., & Anderson, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21656-8 · Cited by 39
miR-132/212 is induced by stress and its dysregulation triggers anxiety-related behavior
Aten, S., Page, C. E., Kalidindi, A., Wheaton, K. L., Niraula, A., Godbout, J. P., Hoyt, K. R., & Obrietan, K. H. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.020 · Cited by 40
Precision Therapy for Epilepsy Related to Brain Malformations
D’Gama, A. M., & Poduri, A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01122-6 · Cited by 40
Gong, X., Zhang, L., Huang, T., Lin, T. V., Miyares, L. C., Wen, J. H., Hsieh, L. S., & Bordey, A. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv295 · Cited by 39
Urbano, M. R., Okwara, L., Manser, P., Hartmann, K., & Deutsch, S. I. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13070155 · Cited by 43
Niere, F., Namjoshi, S., Song, E., Dilly, G. A., Schoenhard, G., Zemelman, B. V., Mechref, Y., & Raab-Graham, K. F. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.055079 · Cited by 38
Nguyen, L. H., Xu, Y., Nair, M., & Bordey, A. (2024) · eLife · doi:10.7554/elife.91010 · Cited by 37
Metadata
- Authors
- Zhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., Powell, C. M., & Parada, L. F.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- The University of Texas at Dallas (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-02-11
- Volume
- 29
- Issue
- 6
- Pages
- 1773-1783
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3904448
- OpenAlex
- W2017097994
- Cited by
- 441
- References
- 52
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 17 · 2023: 17 · 2022: 19 · 2021: 22 · 2020: 49 · 2019: 16 · 2018: 24 · 2017: 28 · 2016: 22 · 2015: 37 · 2014: 31 · 2013: 32 · 2012: 39
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- Autism Speaks (AS1270, AS2126)
- Simons Foundation
- National Institute of Mental Health (K08MH065975, R01MH081164)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD065290)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- PTEN, mTORC1, rapamycin, neuronal hypertrophy, neuronal polarity, macrocephaly, autism-like behavior, postmitotic neurons, PI3K/Akt signaling, Lhermitte-Duclos disease, seizures, hippocampus, cortex
- MeSH terms
- Animals, Autistic Disorder, Female, Male, Mice, Inbred C57BL, Neurons, Transcription Factors, Mice, Knockout, Sirolimus, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
